发明名称 |
Pharmaceutical composition for inhibiting immune response through inducing differentiation into regulator T cells and promoting proliferation of regulator T cells |
摘要 |
The present invention relates to new medical use of (tetrahydropyran-4-yl)-[2-phenyl-5-(1,1-dioxo-thiomorpholine-4-yl)methyl-1H-indol-7-yl]amine, and more particularly, to a pharmaceutical composition containing the compound as an active ingredient, which is used for inhibiting an immune response, and/or for inducing differentiation into regulator T cells from undifferentiated T cells and/or promoting proliferation of regulator T cells. |
申请公布号 |
AU2014244744(B2) |
申请公布日期 |
2016.09.01 |
申请号 |
AU20140244744 |
申请日期 |
2014.03.25 |
申请人 |
LG LIFE SCIENCES LTD. |
发明人 |
CHO, SEOK GOO;KIM, NA YOUN;KIM, EUN JUNG;IM, KEON IL;LIM, JUNG YEON;JEON, EUN JOO |
分类号 |
A61K31/404;A61K31/40;A61K39/395;A61P29/00 |
主分类号 |
A61K31/404 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|